FDA: Ameridose issues voluntary recall of all products

November 2, 2012
FDA: ameridose issues voluntary recall of all products
Ameridose, a Massachusetts-based manufacturer of sterile injectable products and oral syringes, is undergoing a voluntary recall of all unexpired products in circulation, according to an Oct. 31 news release issued by the U.S. Food and Drug Administration.

(HealthDay)—Ameridose, a Massachusetts-based manufacturer of sterile injectable products and oral syringes, is undergoing a voluntary recall of all unexpired products in circulation, according to an Oct. 31 news release issued by the U.S. Food and Drug Administration.

As yet, no patients have been reported to have experienced infections or other complications in association with Ameridose products. The recall was prompted out of concern that sterility assurance for products made and distributed by the facility is lacking. This concern was raised by the preliminary findings of an FDA investigation of the manufacturer's facility as part of an ongoing investigation into the fungal linked with Ameridose's sister company, the Compounding Center of Framingham, Mass.

Acknowledging that the recall stems from an abundance of caution rather than an actual adverse event, the FDA is not at this time recommending that physicians follow up with patients who have received Ameridose products, only that they stop using these products and return them. Hospitals, clinics, and other customers with Ameridose products can call the company at 888-820-0622 for guidance on returning the products.

"The FDA's top priority is to ensure that drugs are safe for the American public," Margaret A. Hamburg, M.D., FDA Commissioner, said in a statement.

Explore further: 2nd firm agrees to temporary shutdown in outbreak

More information: More Information

Related Stories

2nd firm agrees to temporary shutdown in outbreak

October 10, 2012
(AP)—A Massachusetts company run by the same executives who operated a specialty pharmacy linked to a fatal meningitis outbreak has agreed to temporarily shut down for inspection by state and federal regulators.

Suit: Firm provided tainted meds in 2002, man died

October 11, 2012
The compounding pharmacy suspected in a deadly meningitis outbreak settled a lawsuit alleging it produced a tainted shot that caused a man's death in 2004, while a pharmaceutical firm with common owners was accused this summer ...

Tainted drug death toll rises to 14 in US

October 11, 2012
The death toll from a deadly meningitis outbreak in the United States blamed on a tainted drug rose to 14 Thursday as the number of cases jumped to 172 in 11 states, health officials said.

US pharmacy linked to outbreak issues wide recall

October 7, 2012
(AP)—The pharmacy that distributed a steroid linked to an outbreak of fungal meningitis has issued a voluntary recall of all of its products, calling the move a precautionary measure.

Recommended for you

Study suggests ending opioid epidemic will take years

July 20, 2017
The question of how to stem the nation's opioid epidemic now has a major detailed response. A new study chaired by University of Virginia School of Law Professor Richard Bonnie provides extensive recommendations for curbing ...

Team-based model reduces prescription opioid use among patients with chronic pain by 40 percent

July 17, 2017
A new, team-based, primary care model is decreasing prescription opioid use among patients with chronic pain by 40 percent, according to a new study out of Boston Medical Center's Grayken Center for Addiction Medicine, which ...

Private clinics' peddling of unproven stem cell treatments is unsafe and unethical

July 7, 2017
Stem cell science is an area of medical research that continues to offer great promise. But as this week's paper in Science Translational Medicine highlights, a growing number of clinics around the globe, including in Australia, ...

Popular heartburn drugs linked to higher death risk

July 4, 2017
Popular heartburn drugs called proton pump inhibitors (PPIs) have been linked to a variety of health problems, including serious kidney damage, bone fractures and dementia. Now, a new study from Washington University School ...

Most reproductive-age women using opioids also use another substance

June 30, 2017
The majority of reproductive-age and pregnant women who use opioids for non-medical purposes also use at least one other substance, ranging from nicotine or alcohol to cocaine, according to a University of Pittsburgh Graduate ...

At-risk chronic pain patients taper opioids successfully with psychological tools

June 28, 2017
Psychological support and new coping skills are helping patients at high risk of developing chronic pain and long-term, high-dose opioid use taper their opioids and rebuild their lives with activities that are meaningful ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.